Earth Science Tech Inc. Balances Healthcare Expansion with Aggressive Share Repurchases

Earth Science Tech Inc. (OTC: ETST) has evolved into a diversified healthcare holding company with operations spanning telemedicine, compounding pharmacies, clinical support services and healthcare fulfillment. In addition to expanding its operating platform, the company has actively reduced its share count through a series of share repurchases documented in SEC filings and share structure records.

According to the company's most recent Form 10-Q, covering the quarter ended December 31, 2025, Earth Science Tech repurchased 1,143,000 common shares during the quarter for approximately $647,000. Over the nine months ended December 31, 2025, the company repurchased a total of 3.7 million shares. This sustained buyback program underscores management's commitment to enhancing shareholder value through balance-sheet management alongside acquisitions and operating growth.

For many investors evaluating companies on the OTC market, share structure often receives as much attention as revenue growth or acquisition activity. Earth Science Tech's approach of pairing healthcare expansion with aggressive share repurchases has increasingly distinguished it in terms of share structure and financial stability. The company's strategic focus on reducing outstanding shares while simultaneously expanding its healthcare-focused operating platform reflects a disciplined capital allocation strategy.

Earth Science Tech is scheduled to present to investors at the Planet MicroCap Las Vegas 2026 conference in June, providing an opportunity to showcase its progress and future plans. More details on the repurchase program can be found in the company's SEC filing here.

The company continues to emphasize shareholder value through a combination of operational growth, strategic acquisitions, and careful management of its share structure. As Earth Science Tech expands its healthcare footprint, its ongoing share repurchase program signals confidence in the company's future prospects and a commitment to rewarding shareholders.